A Study on the Relationship Between Vitamin B12 Levels and Lipid Profile in Serum of Type 2 Diabetic Patients with Dyslipidemia in Thi Qar Province, Iraq
DOI:
https://doi.org/10.32792/utq/utjsci/v12i2.1406Keywords:
Clinical chemistry ArticleAbstract
This study aimed to investigate the relationship between serum vitamin B12 concentrations and lipid profiles in type 2 diabetic patients with dyslipidemia. We conducted this study in Thi Qar Province, Iraq, during the late summer and early fall of 2023. The investigation included 50 patients with confirmed type 2 diabetes and a comparison group of 50 healthy volunteers who helped establish baseline values. The findings were quite revealing that patients dealing with dyslipidemia showed much higher triglyceride, total cholesterol, LDL, and VLDL levels than our control group (P≤0.05). Conversely, HDL cholesterol levels were significantly reduced in this group (P≤0.05). we also noticed that Type 2 diabetics with dyslipidemia had considerably worse lipid profiles compared to those with normal lipid measurements. We found a relationship between vitamin B12 levels and abnormal lipid patterns in the dyslipidemia group. These findings suggest that monitoring vitamin B12 status should be considered as part of comprehensive lipid management strategies in type 2 diabetic patients. Our findings open doors to potential new treatment approaches, as B12 deficiency might be playing a significant role in lipid disorders among Type 2 diabetics - something that's often overlooked in current treatment protocols.
Received: 2025-05-18
Revised: 2025-06-26
Accepted:2025-06-29
References
A. Rahman and S. Islam, "The complications of long time treatment of insulin therapy in type-2 diabetes patients: A Review," Mol. Mech. Res, vol. 2, pp. 3-4, 2024.
Y. Dhurandhar et al., "Chronic inflammation in obesity and neurodegenerative diseases: exploring the link in disease onset and progression," Mol. Biol. Rep., vol. 52, no. 1, pp. 1–20, 2025.
S. A. A. Latheef, B. S. Reddy, and B. M. Reddy, "An exploratory study of the non-communicable disease risk factors in an endogamous caste population of Reddys from Tirupati, India," J. Anthropol. Surv. India, vol. 17, no. 2, pp. 5–11, 2023.
A. A. Lauer et al., "Mechanistic link between vitamin B12 and Alzheimer's disease," Biomolecules, vol. 12, no. 1, p. 9, 2022.
W. Martin, Vitamin Deficiency. Oslo, Norway: Publifye AS, p. 99_115, 2025.
N. Soleimani, F. Ebrahimi, and M. Mirzaei, "Self-management education for hypertension, diabetes, and dyslipidemia as major risk factors for cardiovascular disease: Insights from stakeholders’ experiences and expectations," PLoS ONE, vol. 19, no. 9, p. 11, 2024.
Y. Liu et al., "Associations of serum folate and vitamin B12 levels with cardiovascular disease mortality among patients with type 2 diabetes," JAMA Netw. Open, vol. 5, no. 1, p. e2, 2022.
J. He, D. Jiang, X. Cui, and C. Ji, "Vitamin B12 status and folic acid/vitamin B12 related to the risk of gestational diabetes mellitus in pregnancy: a systematic review and meta-analysis of observational studies," BMC Pregnancy Childbirth, vol. 22, no. 1, p. 7, 2022.
H. H. Wu, T. McDonnell, and R. Chinnadurai, "Physiological associations between vitamin B deficiency and diabetic kidney disease," Biomedicines, vol. 11, no. 4, p. 11, 2023.
J. Samavat et al., "Maternal B12 deficiency during pregnancy dysregulates fatty acid metabolism and induces inflammation in human adipose tissue," BMC Med., vol. 23, no. 1, p. 3, 2025.
S. Mukherjee et al., "Therapeutic effect of targeted antioxidant natural products," Discov. Nano, vol. 19, no. 1, p. 14, 2024.
M. I. Alam, S. Kumar, and C. Gupta, "A review on advancements in research on the interplay between vitamins and diabetes," Int. J. Newgen Res. Pharm. Healthc., pp. 6–10, 2024.
W. L. Sun et al., "Microbially produced vitamin B12 contributes to the lipid-lowering effect of silymarin," Nat. Commun., vol. 14, no. 1, p. 3-6 2023.
M. N. Al-Qusous, W. K. J. Al Madanat, and R. M. Hussein, "Association of vitamins D, B6, and B12 deficiencies with hyperlipidemia among Jordanian adults," Rep. Biochem. Mol. Biol., vol. 12, no. 3, pp. 3–4, 2023.
H. R. Talari et al., "The effects of vitamin B12 supplementation on metabolic profile of patients with non-alcoholic fatty liver disease: a randomized controlled trial," Sci. Rep., vol. 12, no. 1, p. 17, 2022.
K. N. J. Musafer et al., "The impact of some vitamins and minerals supplements on type 2 diabetes (T2DM) management: The dietary supplements in T2DM management," J. Trop. Life Sci., vol. 14, no. 2, pp. 2–6, 2024.
P. V. Dludla et al., "Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress," World J. Diabetes, vol. 14, no. 3, p. 13, 2023.
P. Jamadade et al., "Therapeutic monoclonal antibodies for metabolic disorders: Major advancements and future perspectives," Curr. Atheroscler. Rep., vol. 26, no. 10, pp. 5–7, 2024.
A. Kontush, Cholesterol, Lipoproteins, and Cardiovascular Health: Separating the Good (HDL), the Bad (LDL), and the Remnant. Wiley, 2024.
O. Albitar, C. M. D’Souza, and E. A. Adeghate, "Effects of lipoproteins on metabolic health," Nutrients, vol. 16, no. 13, p. 26, 2024.
M. Lee-Rueckert et al., "Lipid-laden macrophages and inflammation in atherosclerosis and cancer: an integrative view," Front. Cardiovasc. Med., vol. 9, p. 22, 2022.
N. Ali, D. M. Diamond, and S. M. Rice, "Cardiovascular disease and its association with insulin resistance and cholesterol," in Ketogenic, Academic Press, 2023, pp. 2–6.
F. R. Maxfield, N. Steinfeld, and C. I. J. Ma, "The formation and consequences of cholesterol-rich deposits in atherosclerotic lesions," Front. Cardiovasc. Med., vol. 10, p. 4, 2023.
P. S. Batulwar and A. Anjankar, "Individuals diagnosed with type 2 diabetes mellitus and the status of vitamin B12 deficiency: A review," Cureus, vol. 16, no. 2, 2024.
M. A. Wallig, A. Usborne, and K. P. Keenan, "Nutritional toxicologic pathology," in Haschek and Rousseaux's Handbook of Toxicologic Pathology, Academic Press, 2023, pp. 1–3.
M. S. Hussain et al., "Long-term use of metformin and vitamin B12 deficiency in diabetes," Curr. Drug Saf., vol. 20, no. 3, pp. 2–3, 2025.
L. M. Affaticati et al., "The impact of clinical factors, vitamin B12 and total cholesterol on severity of Anorexia Nervosa: a multicentric cross-sectional study," Nutrients, vol. 15, no. 23, p. 4, 2023.
A. R. Mathew et al., "Vitamin B12 deficiency and the nervous system: Beyond metabolic decompensation—Comparing biological models and gaining new insights into molecular and cellular mechanisms," Int. J. Mol. Sci., vol. 25, no. 1, p. 5, 2024.
A. B. Tajanpure and P. P. Deshmukh, "The influence of dietary components on gene expression," in Nutrigenomics and Nutraceuticals, Apple Academic Press, 2024, pp. 3–10.
J. E. Mejía-Guzmán et al., "Metabolic-dysfunction-associated steatotic liver disease: molecular mechanisms, clinical implications, and emerging therapeutic strategies," Int. J. Mol. Sci., vol. 26, no. 7, p. 9, 2025.
S. Harikrishnan et al., "Vitamin B12: prevention of human beings from lethal diseases and its food application," J. Sci. Food Agric., vol. 105, no. 1, pp. 10–18, 2025.
A. Gospodarczyk et al., "Homocysteine and cardiovascular disease—a current review," Wiad. Lek., vol. 75, no. 11 pt 2, pp. 9, 2022.
F. Tang et al., "Mitochondrial metabolite methylmalonic acid, subclinical myocardial injury, and its incremental predictive value for cardiovascular mortality risk," Arch. Med. Res., vol. 56, no. 6, p. 6, 2025.
I. Tattoli et al., "The interplay between liver and adipose tissue in the onset of liver diseases: Exploring the role of vitamin deficiency," Cells, vol. 13, no. 19, p. 16, 2024.
E. Zarembska, K. Ślusarczyk, and M. Wrzosek, "The implication of a polymorphism in the methylenetetrahydrofolate reductase gene in homocysteine metabolism and related civilisation diseases," Int. J. Mol. Sci., vol. 25, no. 1, p. 9, 2023.
Downloads
Published
License
Copyright (c) 2025 University of Thi-Qar Journal of Science
This work is licensed under a Creative Commons Attribution 4.0 International License.
